Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.

Breast cancer research and treatment - 1 Apr 2010

Abstract excerpt

Menopausal hormone therapy (HT) is associated with an increased breast cancer risk among postmenopausal women. In this study, we investigated genetic effect modification of HT associated breast cancer risk in 3,149 postmenopausal breast cancer patients and 5,489 controls from the two German population-based case-control studies MARIE and GENICA. Twenty-eight polymorphisms of 14 candidate genes including two drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Estrogen Replacement Therapy
Share to Estrogens
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germany

Share to Hormone Replacement Therapy

Share to Odds Ratio

Share to Postmenopause

Share to Progestins

Source

Identifiers

PMID: 19672706
DOI: 10.1007/s10549-009-0489-8

Genes

ABCB1
BRCA1
AURKA
EGFR
ERBB2
IGF1
IGFBP3
LTA
SHBG
TGFB1
TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.PMID 19672706Read ↗

Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.Semantic proximity Read ↗

Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.Semantic proximity Read ↗

Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism.Semantic proximity Read ↗

The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.Semantic proximity Read ↗

Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.Semantic proximity Read ↗

Estrogen-related genes and their contribution to racial differences in breast cancer risk.Semantic proximity Read ↗

Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.Semantic proximity Read ↗

No Association between ABCB1 G2677T/A or C3435T Polymorphisms and Survival of Breast Cancer Patients-A 10-Year Follow-Up Study in the Polish Population.Semantic proximity Read ↗

Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.Semantic proximity Read ↗

Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women.Semantic proximity Read ↗

Evaluation of functional genetic variants for breast cancer risk: results from the Shanghai breast cancer study.Semantic proximity Read ↗

Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.